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We read the article by Leal et al. with interest about a 17-year-old
male with Kearns–Sayre syndrome (KSS), diagnosed upon the
clinical presentation, instrumental findings and the muscle
biopsy findings [1]. Despite some peculiarities of the phenotype,
the presentation at onset was mild and the further course un-
eventful. We have the following comments and concerns.
The main disadvantage of this case report is that the diagno-
sis was not genetically confirmed. Since phenotypic features of
mitochondrial disorders (MIDs) may overlap in various syndrom-
ic MIDs, it is not reliable to diagnose KSS only upon the clinical
manifestations and muscle biopsy findings. This is of particular
importance since a few cases of KSS were reported which did
not carry a single mtDNA deletion but a mtDNA point mutation
such as the mutation m.3243A>G [2] or m.3249G>A [3]. There
are also KSS patients due to a single mtDNA duplication.
Rarely, KSS patients may present with epilepsy. Did the pre-
sented patient ever undergo EEG recordings? Was paroxysmal
activity recorded indicative of mitochondrial epilepsy? Was
ever any type of seizure observed in the presented patient?
Rarely, KSS patients may develop embolic stroke, resulting
from intracardiac thrombi. Even more rarely, stroke-like episodes,
the phenotypic hallmark of mitochondrial encephalopathy, lactic
acidosis, and stroke-like episode syndrome, have been reported in
KSS.Was cerebralMRI indicative of a previous ischemic stroke or a
metabolic stroke manifesting with a stroke-like lesion?
It would also be helpful to know more about the neurological
findings in the presented patient. Were tendon reflexed pre-
served or diminished; was there wasting or muscle weakness;
were there fasciculations, fatigue or exercise intolerance; and
was the gag reflex preserved or abolished? Was there any indica-
tion for dystonia as has been described in some KSS patients?
We should also be informed about the findings on cerebral
imaging since KSS patients may manifest with cerebral
involvement including intellectual decline, dystonia, epilepsy
or encephalopathy.
Rarely, KSS patients may develop dilated cardiomyopathy.
Thus, it is important that KSS patients undergo regular echocar-
diographic investigations and regular clinical cardiologic exam-
ination. Cardiomyopathy is usually accessibly to cardiac
therapy, why adequate treatmentmay improve a patient’s condi-
tion significantly.
Repeatedly, sudden cardiac death has been reported in KSS.
Concerning the indication for implanting an implantable cardio-
verter defibrillator (ICD), KSS patients should undergo regular
Holter monitoring not to overlook ventricular arrhythmias. The
indication for implantation of an ICD should follow the current
guidelines.
Some KSS patients with corneal endothelial dysfunction have
been reported. Did the patient ever complain about corneal pro-
blems? Did ophthalmologic investigations ever detect corneal in-
volvement in the underlying metabolic defect?
KSSmayalso go alongwith hypogonadism.Were hormone le-
vels determined and was pituitary insufficiency excluded?
Finally, there is some confusion concerning the course of
symptoms [1]. The authors mention that the patient was first
seen by them at a ‘regular ophthalmic and general health
check’ [1]. At the same time, they mention that the patient was
not seen by a physician since the last 5 years [1]. When were pto-
sis, ophthalmoplegia, and double vision first recognized? In the
discussion, they mention that the patient was diagnosed with
chronic porgressive external ophthalmoplegia at the age of 21
years, but in the case description, KSS was diagnosed at the age
of 17 years. These contradictory statements require clarification.
Overall, this interesting case presentation could be improved
by genetic studies,more extensivework-up for potentialmultisys-
tem disease and by regular follow-up investigations, particularly
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cardiologic investigations. Additionally, some inconsistencies re-
quire clarification.
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